Publications | Edgars Suna Group

56. S-Alkylation of sulfinamides with Zn-carbenoids: expanding stereoselective sulfoximine synthesis beyond NH derivatives

Jersovs G., Melgalvis D., Kinens A., Donets P. A., Suna E. Org. Chem. Front., 2025, 12, 14-23.
DOI: 10.1039/D4QO01931H

55. Tailoring Emission Lifetime for Dopant-Induced Phosphorescence

Mazarevics, A.; Kinens, A.; Leduskrasts, K.; Suna, E. ACS Materials Lett., 2024, 6, 4590-4595.
DOI: 10.1021/acsmaterialslett.4c01412

54. Impurity-Induced Phosphorescence in Purely Organic Materials

Mazarevics A., Leduskrasts K., Suna E. ACS Materials Lett. 2024, 6, 2703–2713.
DOI: 10.1021/acsmaterialslett.4c00447.

53. Development of Potent Microtubule Targeting Agent by Structural Simplification of Natural Diazonamide

Kalnins T., Vitkovska V., Kazak M., Zelencova-Gopejenko D., Ozola M., Narvaiss N., Makrecka-Kuka M., Domračeva I., Kinens A., Gukalova B., Konrad N., Aav R., Bonato F., Lucena-Agell D., Díaz J. F., Liepinsh E., Suna E. J. Med. Chem., 2024, 67 (11), 9227–9259.
DOI: 10.1021/acs.jmedchem.4c00388.

52. The Novel Adrenergic Agonist ATR-127 Targets Skeletal Muscle and Brown Adipose Tissue to Tackle Diabesity and Steatohepatitis

Talamonti E., Davegardh J., Kalinovich A., van Beek S. M. M., Dehvari N., Halleskog C., Bokhari H. M., Hutchinson D. S., Ham S., Humphrys L. J., Dijon N. C., Motso A., Sandstrom A., Zacharewicz E., Mutule I., Suna E., Spura J., Ditrychova K., Stoddart L. A., Holliday N. D., Bengtsson T. Molecular Metabolism, 2024, 101931.
DOI: 10.1016/j.molmet.2024.101931.

51. Chiral 4-MeO-Pyridine (MOPY) Catalyst for Enantioselective Cyclopropanation: Attenuation of Lewis Basicity Leads to Improved Catalytic Efficiency

Kluga R., Kinens A., Suna E. Chem. Eur. J. 2024, e202301136
DOI: 10.1002/chem.202301136.

50. Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake – The importance of chirality and ring size of cyclic amines

Jaunsleine, K.; Supe, L.; Spura, J.; van Beek, S.; Sandström, A.; Olsen, J.; Halleskog, C.; Bengtsson, T.; Mutule, I.; Pelcman, B. Bioorganic & Medicinal Chemistry Letters 2024, 97, 129562. DOI: 10.1016/j.bmcl.2023.129562.

49. Synthesis and Evaluation of Novel 5-O-(4-C-Aminoalkyl-β-D-ribofuranosyl) Apramycin Derivatives for the Inhibition of Gram-Negative Pathogens Carrying the Aminoglycoside Phosphotransferase(3′)-Ia Resistance Determinant

Lubriks, D.; Haldimann, K.; Kiliç, F.; Hartmann, M.; Böttger, E. C.; Hobbie, S. N.; Suna, E.; Crich, D. Helv. Chim. Acta 2023, e202300138
DOI: 10.1002/hlca.202300138.

48. Pyrazolidinone-based peptidomimetic SARS-CoV-2 Mpro inhibitors

Jelisejevs D., Bula A. L., Kinena L. Bioorg. Med. Chem. Lett. 2023, 96, 129530
DOI: 10.1016/j.bmcl.2023.129530.

47. Electrochemical Synthesis of Unnatural Amino Acids via Anodic Decarboxylation of N-Acetylamino Malonic Acid Derivatives

Koleda O., Prane K., Suna E. Org. Lett. 2023, 25 (44), 7958–7962.
DOI: https://doi.org/10.1021/acs.orglett.3c02687.

Category "Publications"